103 Carnegie Center, Suite 103
Princeton, NJ 08540,USA
(609) 799-0050
(609) 497-9695




Bruce Wong, M.D.

Senior Pharmaceutical Executive who has led Global Epidemiology and Outcomes Research groups at major Pharmaceutical companies for the past 15 years at Vice President level. Qualified in Medicine and Clinical epidemiology he has broad scientific, medical and operational experience in pharmaceutical value proposition development and communication. His product experience includes the value proposition for some of the industries most successful products including Abilify, Orencia, Rayataz, Baraclude, Sprycel, Erbitux, Plavix, Irbesartan. He has been directly involved in the submission and negotiation of over 400 dossiers throughout the word to achieve market access.

Pharmacoeconomic Consulting and Services

The value proposition of your product to payors may not be your primary consideration during early development when you are concerned with demonstrating efficacy and safety, but if you want to maximize the NPV of your asset in a deal then you need to undertake this work early.

Large Pharmaceutical companies know that pricing, re-imbursement and market access are the realities of the marketplace. Typically they have infrastructure in the form of Outcomes Research, Epidemiology, Marketing research or Pricing and Re-imbursement departments, which in variable ways do the stuff of a "value proposition" for their products. The infrastructure costs for these departments is substantial and justified by large and diverse portfolios which can maintain the minimum critical mass to keep multiple individuals gainfully employed with a sense of purpose.

We can provide to small biotech and health technology venture companies the advantage of large company expertise through our network of associates and experts without the infrastructure costs.

We will work with you to provide the level of service you need, give you options for the development of a value proposition strategy for your product, provide you with a vehicle to execute individual elements of the strategy or provide to you a service which will oversee the execution at any number of third party vendors.

A clear and logically developed value proposition strategy and data will enhance the perceived NPV of your technology or compound.

Our experience has been that few descriptions of product value are presented at the time a deal is considered - if you believe in your product you can imagine the value you are leaving on the table.


All rights reserved.